LOPSL klinikiniai tyrimai Alabama
21 tyrimai dėl LOPSL ieško dalyvių vietose Alabama.
Miestai Alabama
Oficialus tyrimo tekstas (anglų kalba)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Cullman
- Research Site, Mobile
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
- Pulmonary Associates - Mobile- Site Number : 8400151, Mobile
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07190222A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- University of Alabama at Birmingham, Birmingham
Renkami dalyviai2 fazė
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07759245A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
Renkami dalyviai4 fazė
Amžius nuo 40 iki 85 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07053423A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Birmingham
Renkami dalyviai2 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Alabama, Birmingham
Renkami dalyviai2 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Cullman
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Foley
- Research Site, Mobile
- Research Site, Sheffield
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- University of Alabama at Birmingham, Birmingham
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-02 · NCT06603246A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- University of Alabama at Birmingham Lung Health Center, Birmingham
- SEC Clinical Research, Dothan
- Pulmonary Associates of Mobile, P.C., Mobile
Renkami dalyviai2/3 fazė
Amžius nuo 35 iki 80 · Visoms lytims · Atnaujinta 2026-08-31 · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 106, Birmingham
Renkami dalyviai3 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-08-11 · NCT07555483Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
- Cooper Green Mercy Hospital, Birmingham
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 50 iki 99 · Visoms lytims · Atnaujinta 2026-08-06 · NCT07748858Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of Alabama, Lung Health Center, Birmingham
Renkami dalyviai3 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-07-31 · NCT06376994Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- The University of Alabama at Birmingham, Birmingham
Renkami dalyviai
Amžius 22 ir vyresni · Visoms lytims · Atnaujinta 2026-06-23 · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- University of Alabama at Birmingham, Birmingham
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 30 iki 55 · Visoms lytims · Atnaujinta 2026-06-03 · NCT05033990Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
Renkami dalyviai
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-04-28 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of Alabama at Birmingham, Birmingham
Renkami dalyviai
Amžius nuo 40 iki 84 · Visoms lytims · Atnaujinta 2026-04-24 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Sheffield
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-04-09 · NCT06961214PiMZ Longitudinal Cohort (PiMZ Logic)
- University of Alabama at Birmingham, Birmingham
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-01-16 · NCT06505603Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
- University of Alabama at Birmingham, Birmingham
Renkami dalyviai4 fazė
Amžius 19 ir vyresni · Visoms lytims · Atnaujinta 2025-11-10 · NCT07135427myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- UAB School of Medicine/Lung Health Center, Birmingham
Renkami dalyviai
Amžius 30 ir vyresni · Visoms lytims · Atnaujinta 2025-02-06 · NCT05204888Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.